Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies

As the development and clinical application of cancer immunotherapies continue to expand, so does the need for novel methods to dissect their mechanisms of action. Antibodies are important effector molecules in cancer therapies due to their potential to bind directly to surface-expressed antigens an...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vloten, Jacob P., Klafuric, Elaine M., Karimi, Khalil, McFadden, Grant, Petrik, James J., Wootton, Sarah K., Bridle, Byram W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677899/
https://www.ncbi.nlm.nih.gov/pubmed/31388514
http://dx.doi.org/10.1016/j.omtm.2019.06.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677899/
https://www.ncbi.nlm.nih.gov/pubmed/31388514
http://dx.doi.org/10.1016/j.omtm.2019.06.010

Ejemplares similares